Ermelinda De Maio

Endocrine Effects of Adjuvant Letrozole Compared With Tamoxifen in Hormone-Responsive Postmenopausal Patients With Early Breast Cancer: The HOBOE Trial

Emanuela Rossi, Alessandro Morabito, Francesca Di Rella et al. · Journal of Clinical Oncology · 2009 · 80 citations

Tamoxifen Result, Hormonal Contraceptive, Breast Oncology +19

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Francesco Perrone, Michelino De Laurentiis, Sabino De Placido et al. · European Journal of Cancer · 2019 · 68 citations

Ovarian Function Suppression, Oncology, Breast Oncology +13

Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial

Francesco Perrone, Francesco Nuzzo, Francesca Di Rella et al. · Annals of Oncology · 2014 · 67 citations · Full text

Breast Oncology, Early Breast Cancer, Medicine +9

Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast

A. De Matteis, Francesco Nuzzo, Giuseppe D’Aiuto et al. · Cancer · 2002 · 55 citations · Full text

Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly

Sandro Pignata, Ciro Gallo, Bruno Daniele et al. · Critical Reviews in Oncology/Hematology · 2006 · 52 citations

Hepatology, Medicine, Histopathology +8